Researchers will provide a full breakdown of the study's findings in August. 

The company also named the newest member of its board of directors.

Researchers shared their full analysis in the Journal of the American Heart Association.

Methamphetamine-related heart failure hospitalizations increased 585% from 2008 to 2018, researchers found. 

The new analysis included data from nearly 700 patients who underwent TEER, formerly known as TMVR, over an eight-year period. 

The analysis, published in European Heart Journal Open, also included a look at how COVID-19 may affect these numbers going forward. 

The study's authors called for additional research in this area, noting that it may be beneficial to screen all heart failure patients for cancer.